��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Neurocognitive Improvement with Antiretroviral Therapy among HIV+ Individuals in Sub-Saharan Africa

Topic Infections/AIDS/Prion Disease

Presentation(s) (-)

Poster/Presentation
Number 125

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ned C. Sacktor, MD, FAAN	No disclosure on file
	No disclosure on file
	No disclosure on file
Richard L. Skolasky, BA	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
David B. Clifford, MD, FAAN (Washington University School of Med)	Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care.